Epidermal dendritic cells found in in£amed skin include Langerhans cells and the recently identi¢ed population of in£ammatory dendritic epidermal cells. Another subset of dendritic cells in humans is the plasmacytoid dendritic cell in peripheral blood, which is characterized by the production of large amounts of type I interferon (interferon-a and interferon-b) upon viral infection. We hypothesized that plasmacytoid dendritic cells might be involved in anti-viral defense mechanisms of the skin. Here we investigated plasmacytoid dendritic cells, in£ammatory dendritic epidermal cells, and Langerhans cells in epidermal single cell suspensions of normal looking skin from healthy volunteers and of lesional skin from patients with different in£ammatory skin diseases. Langerhans cells were found in normal and in in£amed skin samples. In normal skin, plasmacytoid dendritic cells and in£am-matory dendritic epidermal cells were low or absent. Lesional skin samples from patients with psoriasis vulgaris and contact dermatitis contained relatively high numbers of both in£ammatory dendritic epidermal cells and plasmacytoid dendritic cells. In contrast, many in£ammatory dendritic epidermal cells but only very few plasmacytoid dendritic cells could be detected in atopic dermatitis lesions. Lupus erythematosus was characterized by high numbers of plasmacytoid dendritic cells but low numbers of in£ammatory dendritic epidermal cells. These results demonstrate that in addition to resident Langerhans cells, plasmacytoid dendritic cells and in£ammatory dendritic epidermal cells are selectively recruited to the skin lesions depending on the type of skin disease. The lack of plasmacytoid dendritic cells in atopic dermatitis may predispose atopic dermatitis patients to viral infections such as eczema herpeticum, a secondary infection of atopic dermatitis lesions with herpes simplex virus. The composition of dendritic cell subsets may help to clarify the etiology of in£ammatory skin diseases and forms the basis for therapeutic intervention with selective microbial molecules such as immunostimulatory CpG oligonucleotides.
Epidermal dendritic cells found in in£amed skin include Langerhans cells and the recently identi¢ed population of in£ammatory dendritic epidermal cells. Another subset of dendritic cells in humans is the plasmacytoid dendritic cell in peripheral blood, which is characterized by the production of large amounts of type I interferon (interferon-a and interferon-b) upon viral infection. We hypothesized that plasmacytoid dendritic cells might be involved in anti-viral defense mechanisms of the skin. Here we investigated plasmacytoid dendritic cells, in£ammatory dendritic epidermal cells, and Langerhans cells in epidermal single cell suspensions of normal looking skin from healthy volunteers and of lesional skin from patients with different in£ammatory skin diseases. Langerhans cells were found in normal and in in£amed skin samples. In normal skin, plasmacytoid dendritic cells and in£am-matory dendritic epidermal cells were low or absent. Lesional skin samples from patients with psoriasis vulgaris and contact dermatitis contained relatively high numbers of both in£ammatory dendritic epidermal cells and plasmacytoid dendritic cells. In contrast, many in£ammatory dendritic epidermal cells but only very few plasmacytoid dendritic cells could be detected in atopic dermatitis lesions. Lupus erythematosus was characterized by high numbers of plasmacytoid dendritic cells but low numbers of in£ammatory dendritic epidermal cells. These results demonstrate that in addition to resident Langerhans cells, plasmacytoid dendritic cells and in£ammatory dendritic epidermal cells are selectively recruited to the skin lesions depending on the type of skin disease. The lack of plasmacytoid dendritic cells in atopic dermatitis may predispose atopic dermatitis patients to viral infections such as eczema herpeticum, a secondary infection of atopic dermatitis lesions with herpes simplex virus. The composition of dendritic cell subsets may help to clarify the etiology of in£ammatory skin diseases and forms the basis for therapeutic intervention with selective microbial molecules such as immunostimulatory CpG oligonucleotides. Key words: £uorescence-activated cell sorter/human/plasmacytoid dendritic cells. J Invest Dermatol 119: 1096^1102, 2002 D endritic cells (DC) link innate and adaptive immunity by their ability to induce appropriate immune responses upon recognition of invading pathogens, thus serving as ''nature' adjuvant'' (Banchereau et al, 2000) . The Langerhans cells (Langerhans, 1868) are the only DC population identi¢ed in normal epidermis (Banchereau and Steinman, 1998) . Langerhans cells are usually located in the suprabasal layer of the epidermis where they form a close network of sentinels that represent a ''¢rst barrier'' of the immune system against the environment (Birbeck et al, 1961; Wollenberg and Bieber, 2002) . Langerhans cells constantly monitor the epidermal microenvironment by taking up antigen and by transporting antigen from the epidermis to regional lymph nodes, where they initiate T cell responses (Stoitzner et al, 2002) .
In contrast to normal skin, which contains only Langerhans cells, two distinct DC populations have been identi¢ed in in£amed epidermis: the classical Langerhans cells containing CD11b^) , and the in£ammatory dendritic epidermal cells (IDEC), which lack Birbeck granules (CD1a (Wollenberg et al, 1996; Bieber et al, 2000) . IDEC express costimulatory molecules in situ (Schuller et al, 2001) , take up mannosylated antigens via mannose receptor-mediated endocytosis , and represent the relevant FceRI-expressing and IgE-binding epidermal DC population in atopic dermatitis (AD) (Wollenberg et al, 1999) . Besides IDEC, other types of DC may enter the skin under certain conditions. The plasmacytoid DC (PDC) is a novel DC subset that seems to be specialized for the detection of viral infection (Cella et al, 1999; Siegal et al, 1999; Galy et al, 2000) . Upon viral infection, PDC produce large amounts of the anti-viral type I interferon (IFN) (IFN-a and IFN-b) and thus form a key component of the anti-viral defense strategy of the immune system. The PDC is identical with the ''natural type I IFN producing cell'' (Cella et al, 1999; Siegal et al, 1999; Galy et al, 2000) , which was described many years ago as a rare CD4 þ /major histocompatibility complex (MHC) II þ population [1:1000 within peripheral blood mononuclear cells (PBMC)] capable of synthesizing extremely high amounts of type I IFN upon viral infection (Abb et al, 1983; Chehimi et al, 1989; Fitzgerald-Bocarsly, 1993) . Upon maturation this cell type develops characteristic features of DC (Cella et al, 1999; Siegal et al, 1999; Kadowaki et al, 2000) .
A better understanding of mechanisms that regulate in¢ltra-tion and function of DC subsets in the skin may lead to new strategies for therapeutic interventions in order to suppress, stimulate, or deviate cutaneous immune responses. In this study we analyzed the presence of three human DC subsets (PDC, IDEC, and Langerhans cells) in skin lesions of patients with di¡erent in£ammatory skin diseases by using a newly developed four-color staining protocol for £ow cytometry, and by using immunohistochemistry with the new PDC-speci¢c antibody BDCA-2 (Dzionek et al, 2001 ).
MATERIALS AND METHODS
Preparation and immunolabeling of epidermal cell suspensions Following written informed consent, skin biopsies were obtained from patients of the dermatology clinic, as approved by the local ethics committee. After local anesthesia, biopsies were taken from chronic in£ammatory skin lesions, which had not been treated for at least 2 wk. Biopsies of normal looking human skin obtained from surgical specimens served as control. Analysis was performed on a total of 26 biopsies: normal human skin (n ¼ 3), AD (n ¼ 9), contact dermatitis (CD, n ¼ 5), psoriasis vulgaris (n ¼ 7), and lupus erythematosus (LE, n ¼ 2). Epidermal single cell suspensions were prepared by a standardized, limited trypsin digestion technique and ¢ltered through a 50 mm nylon mesh as described in detail elsewhere (Wollenberg et al, 1999) .
Cells were washed and resuspended in phosphate-bu¡ered saline. Human serum was added to block nonspeci¢c binding of antibodies. Cells were stained with anti-CD123 -phycoerythrin (PE), anti-HLA-DRPeridinin-chlorophyll-protein (PerCP), anti-CD11c-allophycocyanin (APC), and £uorescein isothiocyanate (FITC)-conjugated lineage cocktail 1, consisting of anti-CD3, anti-CD14, anti-CD16, anti-CD19, anti-CD20, and anti-CD56 (all from Becton Dickinson, Mountain View, CA). In some experiments, anti-CD1a was used instead of anti-CD123, or cells were stained with anti-BDCA-2 (Miltenyi Biotec, Bergisch Gladbach, Germany).
Flow cytometric analysis Flow cytometric data were acquired on a Becton Dickinson FACSCalibur equipped with two lasers (excitation at 488 and 635 nm wave length). Spectral overlap was corrected by appropriate compensation. A life gate based on the physical properties of the cells FSC vs SSC (forward scatter vs side scatter) was set to exclude cell multiplets from acquisition. Data were analyzed using Cellquest software (Becton Dickinson).
Immunohistochemical analysis of PDC in skin sections For immunohistochemical staining, tissue specimens were embedded in Tissue tek (Sakura Finetek, Torrance, CA), cryopreserved in N 2 and stored at^201C. Acetone-¢xed cryosections (4 mm) were prepared and incubated with the PDC-speci¢c monoclonal antibody (MoAb) BDCA-2 (Dzionek et al, 2001) for 1 h at room temperature after blocking endogenous peroxidase activity with 0.3% H 2 O 2 . An IgG1 isotype MoAb was used as negative control. After incubation with biotinylated horse anti-mouse IgG (1/300, Dako A/S, Glostrup, Denmark) for 1 h at room temperature, sections were rinsed and incubated with avidin^biotin peroxidase complex (1/200, Sigma, Deisenhofen, Germany) for 30 min at room temperature. As a next step, 0.01% 3 -amino-9-ethyl-carbazol in 0.1 M Na-acetate bu¡er (pH 5,5, 0.0015% H 2 O 2 , 6% dimethylsulfoxide) was used as chromogen. With this procedure, PDC stained red. Other cellular elements were counterstained with Mayer' hemalaun (blue).
Statistical analysis Data are expressed as mean7SEM. Statistical signi¢cance of di¡erences was determined by the Mann^Whitney U test and the Wilcoxon rank test. Di¡erences were considered statistically signi¢cant for po0.05. Statistical analyses were performed using StatView 4.51 software (Abacus Concepts Inc., Calabasas, CA).
RESULTS
Identi¢cation of Langerhans cells, IDEC, and PDC in human skin DC are characterized by the lack of lineage markers (CD3 for T cells, CD14 for monocytes, CD16 and CD56 for natural killer cells, CD19 and CD20 for B cells) and by the expression of MHC II. Within the CD1a þ population in skin biopsies of patients with in£ammatory skin disease, two DC subsets can be distinguished based on the expression of CD11b:
Normal skin contains only Langerhans cells but no IDEC (Wollenberg et al, 1996 (Wollenberg et al, , 1999 .
In peripheral blood, PDC can be identi¢ed by the expression of MHC II and CD123 within lineage-negative cells (Krug et al, 2002a) . Additional staining with the pan-myeloid marker CD11c allowed a clear separation of PDC from myeloid DC (Fig 1A) . When the same four-color staining was performed on cells derived from in£ammatory skin lesions, a population of PDC could be clearly separated from other DC subsets (Fig 1C) . The identity of PDC was con¢rmed by similar FSC and SSC characteristics as compared with PDC in peripheral blood ( Fig 1A) ; as well as by staining with a new PDC-speci¢c antibody for BDCA-2 (blood DC antigen-2, recently identi¢ed C-type lectin) (Dzionek et al, 2001) , which detected a similar frequency of PDC as the four-color staining protocol (Fig 2) .
In order to identify the other lineage-negative/MHC IIpositive cell subsets, CD123 was replaced by CD1a ( Fig 1C,  fourth panel from left) . A large proportion of CD11c bright cells and of CD11c-intermediate or CD11c-low cells were positive for CD1a suggesting that these cell populations contain Langerhans cells and IDEC ( Fig 1C, fourth panel from left) . CD11b but not the pan-myeloid marker CD11c is an established marker for the distinction of Langerhans cells and IDEC; therefore, we compared the expression level of CD11b and CD11c on CD1a-positive cells (Fig 1B) . Like CD11b, CD11c showed a bright staining of IDEC but was low on Langerhans cells. Thus, like CD11b, CD11c can be used to separate IDEC from Langerhans cells within a CD1a-positive population. As (besides a small proportion of CD11c bright cells) the expression of CD1a and CD123 was mutually exclusive (within MHC II þ /lineage À cells of the skin), a four-color staining (lineage, MHC II, CD11c, CD123) was su⁄cient to simultaneously identify three subsets of DC in human skin: IDEC (CD11c þ þ þ ; CD123^), Langerhans cells (CD11c þ /^; CD123^), and PDC (CD11c^; CD123 þ þ ).
Distinct pro¢le of DC subsets in skin from patients with di¡erent in£ammatory skin diseases Cells positive for CD45 and CD123 have been found in skin lesions of patients with LE by using immunohistologic analysis (Farkas et al, 2001) . To con¢rm the presence of PDC in LE, we performed fourcolor £ow cytometry allowing simultaneous detection and quanti¢cation of PDC, Langerhans cells, and IDEC in single cell suspensions of skin biopsies. In two di¡erent LE patients, PDC represented 0.32% and 0.35% of all epidermal cells in lesional skin. This number of PDC is relatively high considering the percentage of PDC in peripheral blood (0.2^0.4% of all PBMC), and considering the fact that this number re£ects the percentage of PDC within all epidermal cells, including keratinocytes, melanocytes, and others. Besides PDC, Langerhans cells and only low numbers of IDEC were observed in LE ( Fig 3A) .
Next we studied the pro¢le of DC subsets in lesional skin of a number of individual patients with AD (n ¼ 9), psoriasis (n ¼ 6), CD (n ¼ 5), and in skin from healthy donors (n ¼ 3) (Fig 3) . PDC were absent in normal skin. The number of PDC was signi¢cantly lower in skin samples from AD patients as compared with skin samples from patients with psoriasis (p ¼ 0.02) and contact eczema (p ¼ 0.02) (Fig 3C, left panel) . In contrast, high numbers of IDEC were found in all three in£ammatory skin diseases, including AD; IDEC were low or absent in normal skin (po0.05) (Fig 3C, middle panel) . Relatively high numbers of Langerhans cells were found in all samples examined, including normal skin (Fig 3C, right panel Comparing the number of PDC, IDEC, and Langerhans cells within the di¡erent diagnoses (horizontal comparison), the following signi¢cant di¡erences were found: in normal skin, the percentage of Langerhans cells was higher than the percentage of PDC (p ¼ 0.04) or IDEC (p ¼ 0.05). In samples from patients with AD, the numbers of IDEC were higher than the number of Langerhans cells (p ¼ 0.02), and there were much more Langerhans cells than PDC (po0.001). In patients with psoriasis, PDC were always much lower than IDEC (p ¼ 0.01) or Langerhans cells (p ¼ 0.04). Furthermore, in skin samples from patients with CD, the numbers of IDEC were higher than PDC (p ¼ 0.03). Together these results revealed a distinct pro¢le of DC subsets in lesions of di¡erent skin diseases. One of the most intriguing observations was the relative absence of PDC in AD, and the absence of PDC and IDEC in normal skin.
Localization of PDC in lesional skin BDCA-2 has been reported to be selectively expressed on PDC (Dzionek et al,   2001 ). We used the BDCA-2 speci¢c MoAb to con¢rm the presence of PDC in the basal epidermis and papillary dermis of in£amed skin. We evaluated the use of this BDCA-2 antibody to stain speci¢cally PDC in cryosections of human tonsils that contain a relatively high number of PDC. As demonstrated in Fig 4(A) , staining of tonsillar cryosections with BDCA-2 antibodies revealed a considerable number of PDC in the area of high endothelial venules and in the perifollicular T cell areas.
In agreement with our £ow cytometry studies, BDCA-2-positive cells were absent in both epidermis and dermis of healthy volunteers (not shown), supporting the PDC speci¢city of the BDCA-2 antibodies (Dzionek et al, 2001 ).
In lesional skin of patients with psoriasis, BDCA-2-positive cells were detected in the basal layer of the epidermis and the papillary dermis (Fig 4B,C) . In addition to providing information on localization of PDC, immunohistochemistry with BDCA-2 also con¢rmed our results of the presence of PDC in in£ammatory skin lesions obtained by £ow cytometry. 
DISCUSSION
Langerhans cells play an established role as sentinels in normal skin. Recent observations provide evidence that humans have different subsets of DC, which are specialized for the detection of various pathogen-derived microbial molecules (Enk et al, 1993; Krug et al, 2002b; . The immune system seems to employ di¡erent DC subsets to trigger di¡erent sets of immune responses appropriate for the defense against the corresponding pathogens. In this study, we use a technique that allows the simultaneous detection of PDC, IDEC, and Langerhans cells in skin samples of di¡erent in£ammatory skin diseases. Our studies showed that PDC were as frequent in lesional skin of psoriasis, CD, and LE as in peripheral blood, whereas PDC were reduced or absent in AD and in normal skin. PDC were localized in the basal layer of the epidermis and the papillary dermis. High numbers of IDEC were found in AD, psoriasis, and CD, whereas IDEC were low or absent in LE and in normal skin. Langerhans cells were found in all skin samples, but were highest in normal skin.
Without clinical information such as the history and distribution pattern of the lesions, it is often di⁄cult to establish the correct diagnosis of in£ammatory skin diseases on histology alone. Epidermal DC phenotyping has been reported to contribute to the accurate diagnosis of in£ammatory skin diseases (Wollenberg et al, 1995 (Wollenberg et al, , 1999 . In this study we demonstrate an improved technique that allows a quantitative assessment of Langerhans cells, IDEC, and PDC in skin biopsies. Quanti¢cation of DC subsets may help to distinguish lesional skin from AD, psoriasis, CD, and normal skin.
PDC have been named DC2 based on studies demonstrating that CD40 ligand-activated PDC promote T helper (Th)2 responses (Rissoan et al, 1999; Liu and Blom, 2000; . Others have questioned this view of PDC as DC2 by showing that PDC stimulated by a virus can induce a Th1 response [IFNg4interleukin (IL)-4] or Th0 response (T cells that produce both IFN-g and IL-10) (Cella et al, 2000; Kadowaki et al, 2000) . PDC express a limited toll like receptor (TLR) pro¢le, including TLR9 (Krug et al, 2002b) , which is known to be involved in the recognition of CpG motifs within microbial DNA (Hartmann and Krieg, 2000; Hemmi et al, 2000; Krug et al, 2001; Hornung et al, 2002) . There are hints that PDC may be involved in the pathogenesis of autoimmune diseases (Ronnblom and Alm, 2001) , allergy (Jahnsen et al, 2000) , viral infections (Donaghy et al, 2001; Feldman et al, 2001; Patterson et al, 2001) , and cancer (Zou et al, 2001) .
It has been proposed that the phenotype of the epidermal DC subsets may re£ect the disease-speci¢c microenvironment associated with di¡erent disease entities and thus may provide additional information about the etiology of the disease (Wollenberg et al, 1999) . For example, the microenvironment of in£amed AD skin, which is characterized by an increased production of Th2 cytokines (IL-4 and IL-13) in the acute skin lesions and is frequently associated with an increased total serum IgE (Leung, 2000; Wollenberg et al, 2000) , may account for the selective lack of PDC in AD lesions. Th2 cytokines are thought to play a part in the pathogenesis of AD by enhancing IgE synthesis, eosinophilia, and induction of molecules that are involved in the migration of in£ammatory cells into the skin lesions (Schleimer et al, 1992; Akdis et al, 1997) . Exposure of PDC to the Th2 cytokine IL-4 leads to rapid cell death of PDC, an e¡ect that is potentiated by IL-10, but blocked by CD40 ligand and IFN-g (Rissoan et al, 1999) . The Th2 bias with increased IL-4 and decreased IFN-g in the microenvironment of early AD lesions may induce cell death in those PDC that in¢ltrate these areas. Despite the low numbers of PDC found within the skin lesions, the number of circulating PDC seems to be increased in patients with AD (Uchida et al, 2001) . One possible explanation for these seemingly contradictory ¢ndings is that the increased number of circulating PDC may compensate for the PDC loss in AD skin.
As PDC are regarded the key sensors of viral infection and play an important part in the initiation of anti-viral immune responses by producing large amounts of the anti-viral cytokine type I IFN (Cella et al, 1999) , the lack of PDC in lesional skin of AD patients is in good accordance with the clinically known predisposition of atopic individuals to cutaneous infections. Whereas nonatopics may easily clear human papillomavirus or molluscum contagiosum virus infection from their skin by mounting antiviral immune responses employing their type I IFN producing PDC, the impaired PDC recruitment of atopic individuals may help to explain the long known susceptibility of atopic individuals to cutaneous infections. This concept ¢ts with our ¢nding that disseminated skin infections with the herpes simplex virus known as eczema herpeticum occurs almost exclusively in AD patients (Bork and Brauninger, 1988; Wollenberg et al, 1997) . The impaired ability of AD patients to recruit PDC to their skin lesions may be the immunologic basis for eczema herpeticum, which still represents the most severe and feared complication of AD (Bork and Brauninger, 1988) . Eczema herpeticum is uncommon in patients with CD and psoriasis (Morganroth et al, 1992; Wollenberg et al, 1997) , both of whom contain considerable numbers of PDC in their skin lesions as demonstrated in this study.
PDC are thought to play a speci¢c role in the pathogenesis of LE, in which high systemic IFN-a levels are associated with disease activity (Ronnblom and Alm, 2001 ). We found a higher Fig 1A) . (C) The mean frequencies of PDC, IDEC, and Langerhans cells (7SEM) are compared between normal skin (n ¼ 3), AD (n ¼ 9), psoriasis vulgaris (n ¼ 6, patients not identical with the six patients in Fig 2) , and CD (n ¼ 5). Note di¡erent scale of the x axis. Statistical signi¢cance was determined by Mann^Whitney U test ( n po0.05).
frequency of PDC in the skin lesions of LE as compared with peripheral blood. These results are in agreement with another study, in which PDC were identi¢ed by immunohistochemical staining (CD123 and CD45) in skin lesions of LE patients but not in normal skin (Farkas et al, 2001) . LE is an autoimmune disorder associated with anti-DNA antibodies and increased IFN-a/ b production. Anti-double-stranded DNA antibodies in combination with immunostimulatory plasmid DNA mimic the endogenous IFN-a inducer in systemic LE (Vallin et al, 1999) . PDC have been found to produce IFN-a in response to plasmid DNA/anti-DNA antibody complexes (Dzionek et al, 2001) .
With regard to the pathogenic role of PDC in di¡erent situations, besides viral infection, so far CpG DNA is the only de¢ned microbial stimulus that is recognized by PDC (Kadowaki et al, 2001; Krug et al, 2002b) . CpG DNA mimics the presence of microbial DNA, promoting survival and maturation of PDC (Hartmann et al, 1999) , stimulates the production of IFN-a (Krug et al, 2002a) and IL-12 (Krug et al, 2002b) , and promotes an IL-12-dependent Th1 response. In the absence of the appropriate stimulation, PDC are known to support a Th2 response (DC2) . Little is known about the properties of PDC at e¡ector sites with direct antigen exposure, such as the skin and mucosa. Synthetic CpG ODN might be useful to protect against viral infections such as eczema herpeticum by supporting PDC survival and by inducing the production of Th1 cytokines IFN-a and IL-12 by PDC.
The regular presence of PDC in LE, psoriasis, and CD but striking rareness of PDC in AD suggests a distinctive pathogenetic role of this cell type in in£ammatory skin diseases, which provides a rationale why patients with AD show a predisposition to viral skin infections, such as eczema herpeticum. The function of the PDC with its speci¢c properties is likely to ¢ll some of the gaps in our understanding of the pathophysiology of in£amma-tory skin diseases. PDC may also be a novel target for the immunotherapy of such disorders. 
